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Abstract
Objective
The aim of this study was to investigate the effects of chronic treatment with atrial natriuretic
peptide (ANP) on renal function, nitric oxide (NO) system, oxidative stress, collagen content
and apoptosis in kidneys of spontaneously hypertensive rats (SHR), as well as sex-related
differences in the response to the treatment.
Methods
10 week-old male and female SHR were infused with ANP (100 ng/h/rat) or saline (NaCl
0.9%) for 14 days (subcutaneous osmotic pumps). Systolic blood pressure (SBP) was re-
corded and diuresis and natriuresis were determined. After treatment, renal NO synthase
(NOS) activity and eNOS expression were evaluated. Thiobarbituric acid-reactive sub-
stances (TBARS), glutathione concentration and glutathione peroxidase (GPx) and super-
oxide dismutase (SOD) activities were determined in the kidney. Collagen was identified in
renal slices by Sirius red staining and apoptosis by Tunel assay.
Results
Female SHR showed lower SBP, oxidative stress, collagen content and apoptosis in kid-
ney, and higher renal NOS activity and eNOS protein content, than males. ANP lowered
SBP, increased diuresis, natriuresis, renal NOS activity and eNOS expression in both
sexes. Renal response to ANP was more marked in females than in males. In kidney, ANP
reduced TBARS, renal collagen content and apoptosis, and increased glutathione concen-
tration and activity of GPx and SOD enzymes in both sexes.
Conclusions
Female SHR exhibited less organ damage than males. Chronic ANP treatment would
ameliorate hypertension and end-organ damage in the kidney by reducing oxidative
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stress, increasing NO-system activity, and diminishing collagen content and apoptosis, in
both sexes.
Introduction
It is well established that blood pressure is higher in men than age-match premenopausal
women. However, after menopause, the prevalence of hypertension in women is higher than it
is in men [1, 2]. Moreover, progression of hypertensive renal disease tends to be milder in fe-
males, with a favorable influence in the physiopathology of hypertension and secondary kidney
damage [3, 4].
Atrial natriuretic peptide (ANP) is mainly expressed and stored in granules in the heart
atria and elicits its effects by binding primarily with A-type natriuretic peptide receptor (NPR-
A) and inducing natriuresis, diuresis and vasorelaxation, [5, 6]. The actions of this peptide in-
volve an increase in glomerular filtration rate, inhibition of sodium and water reabsorption,
and a reduction in renin secretion [6]. Nishikimi T et al. have demonstrated, in mice, that ANP
has antifibrotic effects on the kidney, involving the activation of NPR-A and/or C-type natri-
uretic peptide receptor (NPR-C), producing an increase in renal cGMP levels and a decrease in
transforming growth factor beta (TGF-β) expression and collagen I and III content [7]. Fur-
ther, in our laboratory we provided evidence that ANP exerts a hypotensive effect through en-
hancement of cardiovascular and renal NOS activity, in both, normotensive and hypertensive
rats [8–10].
Little is known about the relationship between natriuretic peptides and reactive oxygen spe-
cies (ROS) in renal physiopathology. It has been reported that ANP counteracts ROS genera-
tion in aortic smooth muscle cells and inhibits ROS-induced cell damage via the GC-A/cGMP
pathway [11, 12]. Renal oxidative stress can be a cause, a consequence, or more likely a potenti-
ating factor for hypertension. While animal and human studies have established that ANP re-
duces oxidative stress in the cardiovascular system, in hypertension its antioxidant effect on
the kidney has not been established yet [13–15].
Depending on the experimental conditions and cell context, ANP has antiapoptotic or proa-
poptotic properties [16]. In a recent study we have described that chronic treatment with ANP
promotes antiapoptotic effects on the heart in SHR of both sexes, and this is accompanied by a
reduction in cardiac oxidative stress, fibrosis and hypertrophy [14].
Different authors have shown that estrogens exhibit antioxidant, antiapoptotic and antipro-
liferative effects and that these actions are mediated, in part, by NO-system activation [17–19].
These sexual hormones protect against the development of glomerulosclerosis in a model of
subtotal renal ablation in female rats [20]. In addition, estradiol decreases the local synthesis of
angiotensin-II, endothelin-1, free radicals and lipid peroxides in the kidney [21].
Taking into account this background and our previous studies showing that ANP has cardi-
ac benefits in hypertensive animals [14], we hypothesized that long-term treatment with ANP
induces renal benefits in SHR and that there are sex differences in the response to this chronic
treatment. Therefore, we proposed to investigate morphological changes as well as, antioxidant
and antiapoptotic effects of chronic treatment with ANP on the kidney of SHR rats, and wheth-
er sex differences existed.
Renal Effects of ANP in SHR: Sex Differences
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Materials and Methods
Animals
Ten-week-old male and female SHR were purchased from Instituto de Investigaciones Médicas
A. Lanari, Facultad de Medicina (Universidad de Buenos Aires, Argentina). Rats were housed
in a humidity and temperature-controlled environment with an automatic 12-hour light-dark
cycle. They were fed standard rat chow from Nutrimentos Purina (Buenos Aires, Argentina)
and tap water ad libitum up to the day of the experiments.
Experimental design
All experimental protocols were performed in accordance with the Guide for the Care and Use
of laboratory Animals (National Institutes of Health, Publication No. 85-23, Revised 1996) and
with regulation 6344/96 of Argentina‘s National Drug, Food and Medical Technology Admin-
istration (ANMAT). Experimental procedures were approved by the Ethics Committee of the
School of Biochemistry and Pharmacy (CEFFB), Universidad de Buenos Aires, Buenos Aires,
Argentina.
Protocol
Animals were separated by sex and then randomly assigned to the ANP treated group (n = 12):
chronic infusion with ANP (100 ng/h/rat), or the Control group (n = 12): chronic infusion
with NaCl 0,9%, during 14 days. Chronic infusion in both groups was performed using Alzet
micro-osmotic pumps (Model 1002), prepared according to the manufacturer’s instructions
and implanted subcutaneously between the scapulae using aseptic technique under light
ether anaesthesia.
Systolic blood pressure (SBP) was recorded, 24-hour urine volume was measured and urine
samples were collected at the end of the experimental period in all groups of animals. SBP was
measured in awake animals (tail cuff method) with a MP100 Pulse Transducer, PanLab (Quad
Bridge Amp, ADInstruments), and recorded with a polygraph (Quad Bridge Amp, ADInstru-
ments). Data were obtained using data acquisition software (PowerLab 8/30 and Labchart,
Australia).
Animals were placed in metabolic cages for adaptation to the environment two days before
the beginning of the experiment; after the adaptation period animals were weighed and placed
in metabolic cages in order to collect 24-hour urine. Diuresis was determined gravimetrically
and urinary sodium concentration was measured with an ion analyser (Tecnolab, Model T-
412). The concentration of nitrites and nitrates (NOx), end products derived from NOmetabo-
lism, was determined according to the procedure described by Verdon et al. [22].
Animals were, subsequently euthanized by decapitation and the kidneys were removed and
weighed, in order to evaluate NOS activity and expression, oxidative stress, collagen content
and apoptosis.
Determination of NOS activity
Tissue NOS activity was measured using [14C] L-arginine as substrate, as described previously
[23, 24]. 2–3 mm thick tissue slices were incubated in Krebs solution with 0.5 μCi/ml [14C] L-
arginine for 30 minutes at 37°C. The reaction was stopped by adding 500 μl stop buffer con-
taining 0.5 mM EGTA, 0.5 mM EDTA and 20 mMHEPES (pH 5.5). Tissue samples were then
homogenized in the stop solution and the homogenates were centrifuged at 12,000 g for
20 minutes.
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The supernatants were then applied to a 1ml Dowex AG 50W-X8 column (Na+ form, Bio-
Rad), hydrated with the stop buffer, and eluted with 2 ml of distilled water. The amount of
[14C] L-citrulline was determined with a liquid scintillation counter (Wallac 1414 WinSpec-
tral). Specific NOS activity was assessed in the presence of 10−4 M L-NAME (Sigma). NO pro-
duction in each tube was normalized to the weight of the tissue slices incubated with the
substrate during equal periods of time and expressed as picomoles of [14C] L-citrulline per
gram wet weight per minute.
Western blot analysis
Samples of medulla and cortex from kidney tissue containing equal amounts of protein (0.10 mg
protein/lane) were separated by electrophoresis in 7.5% SDS-polyacrylamide gels, transferred
to a nitrocellulose membrane (Bio-Rad, Munich, Germany), and then incubated with rabbit
polyclonal anti-eNOS antibodies (1/500 dilution, epitope at the NH2 terminus, Santa Cruz Bio-
technology, Santa Cruz, CA) and a horseradish peroxidase-conjugated goat anti-rabbit second-
ary antibody (1/5,000 dilution BioRad Laboratories, USA). A marker of β-actin was used as a
loading control and data were normalized to β-actin expression. Samples were revealed by
chemiluminescence using an enhanced chemiluminescence reagent (Amersham Pharmacia
Biotechnology, Uppsala, Sweden) for 2–4 minutes. A quantification of the bands was per-
formed by digital image analysis using a Hewlett-Packard scanner and Totallab analyzer soft-
ware (Biodynamics, Seattle, WA). All experiments were performed in triplicate [14].
Oxidative stress evaluation
Slices from cortex and medulla of the kidneys were homogenized (OMNI MIXER homogeniz-
er) in 30 mM phosphate buffer potassium, pH 7.4, 120 mM KCl (1g tissue/10 ml buffer). Lipid
oxidative damage was assessed by measuring the extent of formation of 2-thiobarbituric acid
reactive substances (TBARS) [25]. Super oxide dismutase (SOD) activity was assessed by mea-
suring the ability of the homogenate to inhibit autoxidation of epinephrine and was expressed
as units of SOD per milligram of protein [26]. Catalase (CAT) activity was determined by the
conversion of hydrogen peroxide to oxygen and water and was expressed as picomoles per mil-
ligram of protein [27]. The assay described by Flohé and Gunzler was used to measure glutathi-
one peroxidase (GPX) activity and it was expressed as nanomoles per minute per milligram of
protein [28].
In order to measure glutathione content, tissue slices were homogenized in 100 mM phos-
phate buffer sodium, pH 7.0, 5 mM EDTA (1.6 g tissue/10 ml buffer), and centrifuged at
13.000 rpm for 20 minutes at 4°C. Glutathione concentration was measured according to the
method described by Tietze F. and was expressed as milligram per milligram of protein [29].
Protein concentration was determined by the method of Bradford et al. [30].
Histological evaluation and Tunel Assay
Kidneys were cut longitudinally, fixed in phosphate-buffered 10% formaldehyde, pH 7.2, and
embedded in paraffin wax.Kidney sections (3μm) were subjected to collagen-specific Picrosir-
ius Red staining as described previously [31]. Collagen staining was evaluated following a
score: 0 = normal and slight staining surrounding tubular, glomerular and vascular structures;
1 (mild) = weak staining, that doubles normal label, surrounding tubular, glomerular, and vas-
cular structures; 2 (moderate) = moderate staining in the peritubular interstitium and inside
glomeruli; 3 (severe) = strong staining that replaces glomerular and tubular structures,
compromising<25% of the cortical area; and 4 (very severe) = strong staining that replaces
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glomerular and tubular structures, compromising>25% of the cortical area. A score was as-
signed to each section, mainly reflecting the changes in extent rather than intensity of staining.
The DeadEnd Colorimetric TUNEL System, a nonradioactive kit designed to end-label frag-
mented DNA of apoptotic cells, was used as previously described [32]. The number of
TUNEL-positive cells was counted in 20 visual fields (magnification X400) for each rat.
Histological and TUNEL assays were analyzed using an Olympus BX51 light microscope
equipped with a digital camera (QColor 3, Olympus America, Inc., Richmond Hill, Ontario,
Canada) connected to the Image-Pro Plus 4.5.1.29 software (Media Cybernetics, LP, Silver
Spring, MD, USA). Measurements were performed blindly and under similar light, gain, offset,
and magnification conditions.
Statistical Analysis
All values are expressed as means ± SEM. The Prism program (Graph Pad Software, Inc., San
Diego, CA, USA) was used for statistical analysis. The mean and standard error of median val-
ues of each variable were calculated for each group. The results of each variable for each experi-
mental group were analysed with a two-way analysis of variance (ANOVA) where one factor
was the different treatments and the other was sex (male or female). The effects of one factor
were tested independently of the effects of the other, as well as the interaction between both
factors. No interaction between treatments and genotype was found. Multiple comparisons
were performed using a Bonferroni post hoc test. p value< 0.01 was considered a significant
difference.
Results
Effect of chronic treatment with ANP on SBP, diuresis, natriuresis and
NO system
According to our previous findings, SBP was higher in male than in female rats, and chronic
treatment with ANP reduced this parameter in both sexes (Table 1). We found no differences
between sexes in diuresis and natriuresis between sexes, although ANP treatment increased
both parameters in male and female rats (Table 1). Renal response to ANP treatment was more
marked in female than in male SHR (increase in urine volume: Male: 76% and female: 87%; in-
crease in urinary sodium Male: 87% and female: 139%). ANP treatment induced no changes in
Table 1. Effect of chronic treatment with ANP on blood pressure, kidney weight, diuresis and natriuresis in SHR of both sexes.
Male Female
Control ANP Control ANP
BW (g) 303±6 295±8 210±4* 209±4
KW/BW (g/g) 0.42±0.05 0.43±0.04 0.41±0.02 0.41±0.03
SBP (mmHg) 209±8 191±7* 181±6* 168±6†
UV (ml/100g.24h) 3.4±0.5 6.0±0.7* 3.9±0.7 7.3±0.5†‡
UNaV (mEq/24hs) 0.96±0.10 1.80±0.13* 0.93±0.11 2.22±0.15
†‡
BW: body weight; KW: kidney weight; SBP: systolic blood pressure; UV: urinary volume; UNa V: urinary sodium.
Value represents mean ± SEM (n = 12).
*p < 0.01 vs Control Male
†p<0.01 vs Control Female
‡p<0.01 vs ANP male
doi:10.1371/journal.pone.0120362.t001
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kidney weight in either male or female rats. We evaluated NOx excretion as an indicator of NO
systemic production. We observed that female SHR presented higher NOx excretion in 24-
hour urine than male rats, with increased NOx excretion in both sexes after treatment with
ANP (NOx (nmol/min.100g): Control male: 2.6 ± 0.2, Control female: 3.4 ± 0.3, ANP male:
3.8 ± 0.6, ANP female: 4.5 ± 0.4†; p<0.01 vs Control male; †p<0.01 vs Control female).
In order to verify whether the increase in NOx was due to an increase in activity and/or ex-
pression of NOS, NOS activity and expression in renal medulla and cortex was studied to deter-
mine existence of sex differences Fig. 1. Renal activity of the enzyme was higher in female than
in male SHR. Chronic treatment with ANP increased NOS activity in renal medulla and cortex
in both sexes Fig. 1A. The increase of renal NOS activity in response to ANP treatment was
more marked in female than in male SHR (Changes in NOS activity induced by ANP treatment
(pmol/min.100g): Renal cortex: Male: 90.5±10.2 vs Female: 180.4±15.9; Renal medulla: Male:
89.3±8.5 vs Female: 155.7±12.2; p< 0.01). Kidney eNOS protein content was higher in female
than in male SHR, and ANP increased eNOS expression in both sexes Fig. 1B and C.
Study of renal oxidative stress in response to chronic treatment with
ANP
Female kidneys showed less oxidative stress than male ones and displayed higher levels of glu-
tathione and lower content of TBARS when compared to the male group Fig. 2A and B. Chron-
ic treatment with ANP increased the levels of glutathione and reduced TBARS in kidneys of
both sexes. The study of antioxidant enzymes showed that renal activity of CAT was higher in
female than male rats. Renal GPx and SOD activities in female rats were lower when compared
to the male group. Chronic treatment with ANP increased GPx and SOD activities in both
sexes (Table 2).
Sirius Red staining and apoptosis in kidney
Male renal cortex and medulla showed a greater staining for collagen, compared to female rats.
Treatment with ANP reduced collagen content in both tissues and sexes Fig. 3A and B. Exami-
nation of TUNEL-stained kidney sections revealed fewer apoptotic cells in cortex and medulla
of female rats compared to males. ANP treatment decreased the number of apoptotic cells in
renal cortex and medulla in both sexes Fig. 3E and F.
Discussion
In the present study we demonstrated that chronic treatment with ANP exerts beneficial effects
in kidney of SHR, reducing oxidative stress, collagen content and apoptosis. These actions were
also accompanied by an increase in renal NO-system activity. Moreover, we found that impor-
tant sex differences exist in this model of hypertension and in the response to chronic
ANP treatment.
It is well known that ANP modulates arterial blood pressure through different mechanisms
that involve the control of sodium and water excretion, in addition to vasorelaxation. As ex-
pected, chronic treatment with ANP decreased SBP and increased sodium and water excretion.
In previous studies we found that these actions of ANP involved, at least in part, an increase in
renal NOS activity by interacting with natriuretic receptors NPR-A and NPR-C in both normo-
tensive and hypertensive male animals [33].
Our results showed no differences between sexes in diuresis and natriuresis of control
groups. However, the effects of ANP in these parameters were more marked in females. In this
regard, Reckelhoff et al. reported that male SHR not only have higher SBP but also a blunted
pressure-natriuresis relationship compared with female SHR [34]. Although the mechanism
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responsible for the sexual dimorphism in renal function is unknown, this fact could be attribut-
ed to the beneficial effects of estradiol on kidney function, which include higher eNOS activity
in renal vasculature and tubular cells and a reduction in oxidative stress [35–38].
Fig 1. Effects of ANP treatment on renal NOS. (A) Nitric oxide synthase (NOS) activity; (B) Representative
blots of eNOS and β-actin; (C) Quantification of eNOS bands. All experiments were performed in triplicate. β-
actin was used as a loading control and data are normalized to actin expression. White spaces demarcate
noncontiguous gel lanes. Data are mean ± SEM (n = 12). *p<0.01 vs Control male, †p<0.01 vs Control
female.
doi:10.1371/journal.pone.0120362.g001
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Adding to this, chronic ANP increased the activity of renal NOS and eNOS expression in
male and female SHR rats. However, the response of renal NOS to ANP in female rats was
higher than in males, indicating that the presence of estrogens could improve the effect of ANP
on NO-system. Moreover, control female SHR showed not only higher NOx levels, as report
previously [14], but also an increase in the activity and expression of eNOS in renal cortex and
medulla, as well as reduction in kidney oxidative stress compared to male rats, indicating a sex
difference in these parameters.
Experimental and human hypertensive studies documented that NO deficiency mediates
oxidative stress in the kidney [39–41]. Moreover, it was reported that oxidative stress and renal
NO deficiency contributes to the hypertensive state in SHR [42, 43]. Adding to this, previous
studies showed that hypertension is ameliorated or reverted in this model after use of an oxy-
gen radical scavenger [44, 45].
Furthermore, it has been shown, both in humans and animals, that NO level is higher in fe-
males because estrogens not only stimulate NO production but also decrease inactivation of
NO by oxygen radicals [35, 46, 37]. Moreover, epidemiological and experimental evidence
Fig 2. Effects of ANP treatment on renal concentration of glutathione and TBARS. (A) Glut: glutathione; (B) TBARS: thiobarbituric acid reactive
substances. Data are mean ± SEM (n = 12). *p<0.01 vs Control male, †p<0.01 vs Control female.
doi:10.1371/journal.pone.0120362.g002
Table 2. Effect of chronic treatment with ANP on the enzymes involved in renal oxidative state of
male and female SHR.
Male Female
Control ANP Control ANP
CAT (pmol/mg.prot) 0.85±0.06 0.99±0.08 1.33±0.12* 1.41±0.11
SOD (USOD/mg.prot) 8.1±0.6 10.1±0.5* 6.2±0.4* 8.6±0.6†
GPx(μmol/min.mg.prot) 210±21 307±37* 81±9* 157±15†
CAT: Catalase; SOD: superoxide dismutase; GPx: glutathione peroxidase.
Value represents mean ± SEM (n = 12).
*p <0.01 vs control male
†p<0.01 vs control female
doi:10.1371/journal.pone.0120362.t002
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suggests that oxidative stress is enhanced in males compared with females [47, 48]. Additional-
ly, estradiol protects the female kidney in part by attenuating injury-induced increases in renal
superoxide production [49]. Our results show that kidney of female SHR exhibits higher levels
of glutathione and lower content of TBARS than male ones, indicating a sex difference in renal
oxidative status. The increased production of renal free radicals could explain the higher lipid
peroxidation and the lower levels of glutathione content observed in males. Consequently, we
observed increased activity of antioxidant enzymes, SOD and GPx in male kidneys of SHR as a
compensatory response. In this regard, the increased levels of superoxide anion and H2O2
would enhance SOD and GPx activities, respectively. These results are consistent with previous
reports by Sullivan et al. showing that male SHR exhibit greater SOD activity and higher H2O2
levels in renal inner medulla than females [50, 5].
Although, the antioxidant role of ANP has been established in cardiovascular, liver and im-
mune system diseases, little is known about the relationship between ANP and oxidative stress
Fig 3. Sirius Red staining and TUNEL positive apoptotic nuclei in kidney after treatment with ANP. (A) The red colour of Sirius red staining under the
light microscope indicates total collagen deposits, representative images are from renal cortex of each group; (B) Sirius red Score values; (C) Representative
micrographs of TUNEL staining in renal cortex and medulla; (D) Apoptotic cells quantification. C-M: Control male; ANP-M: ANPmale; C-F: Control female;
ANP-F: ANP female. All images are at the samemagnification (400X). Scale bar: 30 μm. Value represents mean ± SEM (n = 12) *p<0.01 vs Control male,
†p<0.01 vs Control female.
doi:10.1371/journal.pone.0120362.g003
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in renal injury [13]. Ogawa Y et al. recently observed that the administration of aldosterone in
NPR-A-deficient mice caused a mayor increase in hypertension, glomerular injury and ROS
than in wild type mice, suggesting a protective role of ANP [51]. In our study, we found that
chronic treatment with ANP decreased oxidative stress in kidney of SHR, reducing lipid perox-
idation in males and increasing glutathione levels in both sexes. Furthermore, these effects are
due to the increase in GPx and SOD activities induced by the peptide in both sexes.
In the present study, we also demonstrated that chronic treatment with ANP decreased the
deposit of collagen in medulla and cortex in both sexes. The increase of NO production as well
as the decrease in renal oxidative stress observed in these animals could explain, at least in part,
these renal effects of ANP. According to our results, it has been recently found that mice carry-
ing a target disruption of a gene coding for NPR-A receptor exhibit renal fibrosis and remodel-
ing, accompanied by an increase in the expression of TGF-β [52].
Moreover, kidneys of females showed minor staining for collagen in both medulla and cor-
tex compared to males. Once more, this could be explained by the fact that estrogens are
known to be nephroprotective not only by decreasing oxidative stress but also by reducing the
generation and deposit of extracellular matrix protein, and by diminishing the expression of
TGF-β [20].
Ortiz et al. have reported that apoptosis of the intrinsic renal cells plays an important role in
the persistence and progression of renal injury [53]. In this regard, the present protocol repre-
sents the first in vivo study that analyzes the effects of ANP treatment on apoptosis in the kid-
ney, showing that chronic treatment with the peptide reduces apoptosis in renal medulla and
cortex of both male and female SHR. In previous studies, we demonstrated that ANP treatment
reduces apoptosis in the cardiac ventricle of both male and female SHR [14].
On the other hand, our results showed that females exhibited less apoptosis in renal medulla
and cortex than males. These results are probably due to the fact that estradiol regulates differ-
ent components of the apoptotic pathway by modulating their expression or activity in diverse
tissues and experimental models [54, 55]. Although, we recently observed that there were no
differences between males and females in the number of apoptotic cells in left ventricle [14],
our present results in kidney are the first evidence of a sex difference in apoptosis in SHR.
Conclusions
In summary, we have demonstrated that the kidney of female SHR presents less collagen de-
posit, apoptosis and oxidative stress in this model of hypertension. Taking into account that
NO exerts antioxidant and antifibrotic effects [56, 57], along with our previous findings linking
ANP and eNOS activation, we can postulate that indirect effects of ANP in kidney would be
mediated, at least in part, by the increase in NO, which also contributes to reduce oxidative
stress.
Whether sex plays an essential role in the onset of hypertension complications and organ
damage continues to be an issue of intense debate, but we found that, in this model of hyper-
tension, female SHR showed less signs of early fibrosis, apoptosis and oxidative stress in the
kidney than male SHR. While we must take into account that males exhibit higher blood pres-
sure values than females, it is important to consider that blood pressure values in females are
also consistent with target organ damage. On the other hand, chronic treatment with ANP not
only lowered SBP but also induced antifibrotic, antiproliferative and antiapoptotic effects in
the kidney of male and female SHR. In accordance with our results, the beneficial effects of
ANP in hypertension probably involve activation of the NO-system and an improvement in
the antioxidant system.
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